We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
A majority of breast and ovarian cancers as well as fractions of cases in the remaining malignancies displayed moderate to strong nuclear immunoreactivity. Malignant cells in general were negative.